MX380387B - Metodos de piolisina y composiciones. - Google Patents

Metodos de piolisina y composiciones.

Info

Publication number
MX380387B
MX380387B MX2017011648A MX2017011648A MX380387B MX 380387 B MX380387 B MX 380387B MX 2017011648 A MX2017011648 A MX 2017011648A MX 2017011648 A MX2017011648 A MX 2017011648A MX 380387 B MX380387 B MX 380387B
Authority
MX
Mexico
Prior art keywords
pyolysin
pyogenes
glucose
compositions
methods
Prior art date
Application number
MX2017011648A
Other languages
English (en)
Other versions
MX2017011648A (es
Inventor
Allen Poppe
George Moutafis
Glenn Andrew Moonen
John Herberg
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2017011648A publication Critical patent/MX2017011648A/es
Publication of MX380387B publication Critical patent/MX380387B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a un método para incrementar el rendimiento de piolisina producida por Trueperella pyogenes, el método caracterizado porque comprende: A) cultivar T.pyogenes en un medio basal que contiene glucosa, así como una fuente de carbono concentrado adicional seleccionada del grupo que consiste de: glucosa, galactosa, sacarosa, maltosa, oligosacáridos, glicerol, lactosa, dextrano, dextrina, succinato de monometilo , y N-acetilglucosamina; B) añadir un agente quelante al medio antes del agotamiento de la glucosa en medio; C) cosechar T.pyogenes, y D) aislar la piolisina.
MX2017011648A 2015-03-12 2016-03-14 Metodos de piolisina y composiciones. MX380387B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562132050P 2015-03-12 2015-03-12
PCT/US2016/022297 WO2016145432A1 (en) 2015-03-12 2016-03-14 Pyolysin methods and compositions

Publications (2)

Publication Number Publication Date
MX2017011648A MX2017011648A (es) 2017-11-02
MX380387B true MX380387B (es) 2025-03-12

Family

ID=55640899

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011648A MX380387B (es) 2015-03-12 2016-03-14 Metodos de piolisina y composiciones.

Country Status (12)

Country Link
US (1) US10858401B2 (es)
EP (1) EP3268380B1 (es)
JP (1) JP6570648B2 (es)
KR (1) KR101999043B1 (es)
CN (1) CN107466326B (es)
AU (1) AU2016228514B2 (es)
BR (1) BR112017019460B1 (es)
CA (1) CA2979541C (es)
DK (1) DK3268380T3 (es)
ES (1) ES2711893T3 (es)
MX (1) MX380387B (es)
WO (1) WO2016145432A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107101933A (zh) * 2017-07-10 2017-08-29 郑州金域临床检验中心(普通合伙) 一种血液分析组合物及其应用
CN116814486B (zh) * 2023-06-26 2024-11-19 青岛农业大学 一种促进化脓隐秘杆菌生长的细菌培养基

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US5210037A (en) * 1988-03-22 1993-05-11 Centocor Incorporated Method to enhance TPA production
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
BR9610775A (pt) * 1995-06-07 1999-07-13 Univ Kansas State Vacinas de actinomyces pyogenes e de actinomyces pyogenes/fusobacterium necrophorum para imunizar gado e carneiros
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
WO2007144647A2 (en) * 2006-06-15 2007-12-21 Timothy John Mitchell Adjuvant compositions
LT5705B (en) * 2009-02-23 2011-01-25 Uab Profarma Monoclonal antibodies against vaginolysin
EP3545970A1 (en) 2012-11-29 2019-10-02 Cornell University Vaccine for intrauterine disease
CN104073450A (zh) * 2014-02-28 2014-10-01 重庆市畜牧科学院 山羊源化脓隐秘杆菌及其应用
CN103937889B (zh) * 2014-04-14 2015-09-30 陕西省动物研究所 一种化脓隐秘杆菌lamp检测用引物及检测方法

Also Published As

Publication number Publication date
CN107466326A (zh) 2017-12-12
WO2016145432A1 (en) 2016-09-15
EP3268380A1 (en) 2018-01-17
JP6570648B2 (ja) 2019-09-04
KR101999043B1 (ko) 2019-07-10
AU2016228514B2 (en) 2021-06-17
US20180057543A1 (en) 2018-03-01
US10858401B2 (en) 2020-12-08
MX2017011648A (es) 2017-11-02
AU2016228514A1 (en) 2017-09-14
ES2711893T3 (es) 2019-05-08
NZ734998A (en) 2024-01-26
CA2979541A1 (en) 2016-09-15
EP3268380B1 (en) 2018-12-26
JP2018507704A (ja) 2018-03-22
BR112017019460A2 (pt) 2018-05-15
KR20170126492A (ko) 2017-11-17
CA2979541C (en) 2019-07-16
BR112017019460B1 (pt) 2023-11-21
CN107466326B (zh) 2021-10-15
DK3268380T3 (en) 2019-02-18

Similar Documents

Publication Publication Date Title
Xu et al. Long-time asymptotics for the Fokas–Lenells equation with decaying initial value problem: without solitons
ECSP18010065A (es) Proceso para la producción de cannabidiol y delta-9-tetrahidrocannabinol
CR20200192A (es) Métodos y composiciones para la producción de nucleósido trifosfatos y ácidos ribonucleicos
PH12020550833A1 (en) Rnai constructs for inhibiting pnpla3 expression
CL2018001339A1 (es) Locus óptimos de la soja (divisional de solicitud 1063-2016)
MX386927B (es) Composicion y metodo para el crecimiento del cabello.
HK1243322A1 (zh) 脂肪酸半胱胺缀合物和它们作为自噬的活化剂的用途
MX2016011467A (es) Poli alfa-1,3-glucano oxidado como mejorador de detergente.
WO2018175258A8 (en) Methods and compositions for preparing nucleic acid libraries
MX367417B (es) Metodos de seleccion para microorganismos que imparten propiedades beneficiosas a las plantas.
ECSP17028310A (es) Composiciones y métodos para inhibir la expresión del gen HAO1 (hidroxiácido-oxidasa 1 (glicolato-oxidasa))
CU24359B1 (es) Un método para convertir una materia prima de biomasa en ácido aspártico y ácido glutámico
AU2013228077B2 (en) Composition for hot-start reverse transcription reaction or hot-start reverse transcription polymerase chain reaction
MX2016013950A (es) Metodo para producir l-aminoacidos utilizando una bacteria alcalifilica.
MX2018002254A (es) Metodo para producir composiciones de edulcorantes y composiciones edulcorantes.
MX2020004643A (es) Composiciones y metodos para mejorar la funcion visual.
MX2023010915A (es) Metodos para preparar ciclooctenos y conjugados de los mismos.
CO2019003427A2 (es) Métodos para mejorar el resabio de bebidas alcohólicas usando alulosa
MX2019003803A (es) Mezclas de sensacion bucal para bebidas bajas en calorias y no caloricas.
MX376782B (es) Métodos de administración de composiciones de amantadina.
WO2014145870A3 (en) Novel compositions, methods and kits for blood typing
MY193587A (en) Genetically modified microorganism for improved production of fine chemicals on sucrose
WO2017035319A8 (en) Methods for treatment of polycystic kidney disease
MX380387B (es) Metodos de piolisina y composiciones.
AR085810A1 (es) Modificacion del color en telas que tienen apresto